Cargando…

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Identification and characterization of molecular mechanisms that connect genetic risk factors to initiation and evolution of disease pathophysiology represent major goals and opportunities for improving therapeutic and diagnostic outcomes in Alzheimer's disease (AD). Integrative genomic analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Readhead, B, Haure-Mirande, J-V, Zhang, B, Haroutunian, V, Gandy, S, Schadt, E E, Dudley, J T, Ehrlich, M E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862938/ https://www.ncbi.nlm.nih.gov/pubmed/26552589 http://dx.doi.org/10.1038/mp.2015.167

Ejemplares similares

Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study
por: Lopez, Susanna, et al.
Publicado: (2020)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer’s disease
por: Tok, S., et al.
Publicado: (2022)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Correction: Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in App(NL-G-F), App(NL-F), and 3xTg-AD mouse models
por: Pauls, Eduardo, et al.
Publicado: (2021)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

From EST to structure models for functional inference of APP, BACE1, PSEN1, PSEN2 genes
por: Aathi, Muthusankar, et al.
Publicado: (2019)

APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
por: Xiao, Xuewen, et al.
Publicado: (2021)

Integrated analysis of behavioral, epigenetic, and gut microbiome analyses in App(NL-G-F), App(NL-F), and wild type mice
por: Kundu, Payel, et al.
Publicado: (2021)

Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
por: van Heusden, Fran C., et al.
Publicado: (2023)

Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice
por: Krivinko, Josh M., et al.
Publicado: (2022)

Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

The associations of APP , PSEN1 , and PSEN2 genes with Alzheimer's disease: A large case–control study in Chinese population
por: Xiao, Xuewen, et al.
Publicado: (2022)

Identification of fibrillogenic regions in human triosephosphate isomerase
por: Carcamo-Noriega, Edson N., et al.
Publicado: (2016)

The neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 may involve elevated levels of α7 nicotinic acetylcholine receptors
por: Cao, Kun, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
por: Lanoiselée, Hélène-Marie, et al.
Publicado: (2017)

Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP/PSEN1 mice
por: Wilcox, J.M., et al.
Publicado: (2021)

Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2022)

Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer’s APP/PSEN1 mice by gene targeting of diabetes/Alzheimer’s-related Sorcs1
por: Knight, Elysse M., et al.
Publicado: (2016)

Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old App(NL/NL) Knock-In Mice
por: Salas, Isabel H., et al.
Publicado: (2018)

Retinal Thickness Changes Over Time in a Murine AD Model APP(NL-F/NL-F)
por: Salobrar-García, Elena, et al.
Publicado: (2021)

Fecal Implants From App(NL–G–F) and App(NL–G–F/E4) Donor Mice Sufficient to Induce Behavioral Phenotypes in Germ-Free Mice
por: Kundu, Payel, et al.
Publicado: (2022)

Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease
por: Tok, S., et al.
Publicado: (2022)

Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ
por: Knight, E M, et al.
Publicado: (2015)

Age-Dependent Behavioral and Metabolic Assessment of App(NL−G−F/NL−G−F) Knock-in (KI) Mice
por: Wang, Shanshan, et al.
Publicado: (2022)

Identification of PSEN1 and APP Gene Mutations in Korean Patients with Early-Onset Alzheimer's Disease
por: Park, Hyun-Kyung, et al.
Publicado: (2008)

Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice
por: Tanifum, Eric A., et al.
Publicado: (2012)

Amyloid β induces interneuron-specific changes in the hippocampus of APP(NL-F) mice
por: Sos, Katalin E., et al.
Publicado: (2020)

iPSC-derived familial Alzheimer’s PSEN2(N141I) cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling
por: Moreno, Cesar L., et al.
Publicado: (2018)

Alzheimer mutant speeds APP transport
por: Gandy, Sam, et al.
Publicado: (2021)

The two faces of synaptic failure in App(NL-G-F) knock-in mice
por: Latif-Hernandez, Amira, et al.
Publicado: (2020)

Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease
por: Sassi, Celeste, et al.
Publicado: (2014)

Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2017)

Regional contributions of D-serine to Alzheimer’s disease pathology in male App(NL–G–F/NL–G–F) mice
por: Ni, Xiance, et al.
Publicado: (2023)

CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2(N141I) neurons
por: Ortiz-Virumbrales, Maitane, et al.
Publicado: (2017)

Effects of proton radiation on evoked and spontaneous neuronal activity in the hippocampus of APP/PSEN1 transgenic mice
por: Rudobeck, Emil, et al.
Publicado: (2014)

Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APP(NL-F/NL-F) knock-in mice
por: Shah, Disha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6s3belmkp1tp4p0huiqk8bitgb